Cargando…

Adoptive Immunotherapy Against Allogeneic Kidney Grafts in Dogs with Stable Hematopoietic Trichimerism

Dogs given nonmyeloablative conditioning and marrow grafts from 2 dog leukocyte antigen (DLA)-identical littermate donors developed stable trichimerism and stably accepted a subsequent kidney graft from one of the marrow donors without the need for immunosuppression. In this study, we used trichimer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graves, Scott S., Hogan, William J., Kuhr, Christian, Diaconescu, Razvan, Harkey, Michael, Sale, George E., Stone, Brad, Georges, George E., Storb, Rainer
Formato:	Texto
Lenguaje:	English
Publicado:	American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2603466/ https://www.ncbi.nlm.nih.gov/pubmed/18940673 http://dx.doi.org/10.1016/j.bbmt.2008.08.005

Ejemplares similares

What Role Is There for Antithymocyte Globulin in Allogeneic Nonmyeloablative Canine Hematopoietic Cell Transplantation?
por: Diaconescu, Razvan, et al.
Publicado: (2005)

Role of Comorbidities in Optimizing Decision-Making for Allogeneic Hematopoietic Cell Transplantation
por: Sorror, Mohamed L., et al.
Publicado: (2010)

Hematopoietic Cell Transplantation Provides an Immune-tolerant Platform for Myoblast Transplantation in Dystrophic Dogs
por: Parker, Maura H, et al.
Publicado: (2008)

Allogeneic peripheral blood haematopoietic stem cell transplantation for the treatment of dogs with high‐grade B‐cell lymphoma
por: Gareau, Alexandra, et al.
Publicado: (2022)

Prognostic factors and outcomes of severe gastrointestinal graft-vs.-host disease after allogeneic hematopoietic cell transplantation
por: Castilla-Llorente, Cristina, et al.
Publicado: (2014)

History of hematopoietic cell transplantation: challenges and progress
por: Granot, Noa, et al.
Publicado: (2020)

Minor Antigen Vaccine-Sensitized DLI: In Vitro Responses Do Not Predict In Vivo Effects
por: Rosinski, Steven Lawrence, et al.
Publicado: (2016)

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: improved outcomes over two decades
por: Cooper, Jason P., et al.
Publicado: (2020)

Anti-CD28 Antibody-Initiated Cytokine Storm in Canines
por: Rosinski, Steven L., et al.
Publicado: (2015)

Genotyping of canine MHC gene DLA‐88 by next‐generation sequencing reveals high frequencies of new allele discovery and gene duplication
por: Pyo, Chul‐Woo, et al.
Publicado: (2022)

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma
por: Maffini, Enrico, et al.
Publicado: (2019)

Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation
por: Graves, Scott S., et al.
Publicado: (2021)

Impact of Pre-Transplant Measurable Residual Disease on Outcome of Allogeneic Hematopoietic Cell Transplantation in Adult Monosomal Karyotype AML
por: Morsink, Linde M., et al.
Publicado: (2020)

Utility of Treatment-Related Mortality (TRM) Score to Predict Outcomes of Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
por: Zarling, Lucas C., et al.
Publicado: (2022)

Comparison of Minimal Residual Disease as Outcome Predictor for AML Patients in First Complete Remission Undergoing Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation
por: Walter, Roland B., et al.
Publicado: (2014)

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies
por: Li, Yawen, et al.
Publicado: (2018)

CD154 Blockade and Donor-Specific Transfusions in DLA-Identical Marrow Transplantation in Dogs Conditioned with 1-Gy Total Body Irradiation
por: Jochum, Christoph, et al.
Publicado: (2007)

Another tool against cytomegalovirus after allogeneic hematopoietic cell transplantation
por: Chen, George L., et al.
Publicado: (2023)

Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
por: Rodríguez-Arbolí, Eduardo, et al.
Publicado: (2022)

GMP-production of purified human B lymphocytes for the adoptive transfer in patients after allogeneic hematopoietic stem cell transplantation
por: Tittlbach, Hannes, et al.
Publicado: (2017)

The Quality of Life of Adult Survivors of Childhood Hematopoietic Cell Transplant
por: Sanders, Jean E., et al.
Publicado: (2009)

Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
por: Morsink, Linde M., et al.
Publicado: (2020)

Institution-independent model theory
por: Diaconescu, Razvan
Publicado: (2008)

Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation
por: Du, Wei, et al.
Publicado: (2018)

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020)

Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy
por: Kim, Hee-Je, et al.
Publicado: (2021)

CD94 Ex Vivo Cultures in a Bone Marrow Transplantation Setting
por: Abrams, Kraig, et al.
Publicado: (2020)

The Use of Allogeneic Hematopoietic Stem Cell Transplantation in Primary Myelofibrosis
por: Wolfe, Heather R., et al.
Publicado: (2022)

The canine gut microbiome is associated with higher risk of gastric dilatation-volvulus and high risk genetic variants of the immune system
por: Hullar, Meredith A. J., et al.
Publicado: (2018)

Potential Risks to Stable Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children With Cerebral X-linked Adrenoleukodystrophy
por: Kühl, Jörn-Sven, et al.
Publicado: (2018)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NEUROBLASTOMA: THE CIBMTR EXPERIENCE
por: Hale, Gregory A., et al.
Publicado: (2013)

High-intensity interval training in allogeneic adoptive T-cell immunotherapy – a big HIT?
por: Heinemann, Nele Carolin, et al.
Publicado: (2020)

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
por: Lupo, Kyle B., et al.
Publicado: (2019)

Abstract 40: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine Model
por: Swearingen, Bruce J., et al.
Publicado: (2018)

Abstract 47: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine DLA-Mismatch Model
por: Swearingen, Bruce J., et al.
Publicado: (2019)

Abstract 48: A Clinically Relevant Protocol for Vascularized Composite Allotransplantation Using A Single Dose of AMD3100 for Stem Cell Mobilization
por: Swearingen, Bruce J., et al.
Publicado: (2017)

Acquired factor V inhibitors after allogeneic hematopoietic stem cell transplantation in a dog
por: Masciana, Joseph, et al.
Publicado: (2020)

Extracorporeal Photopheresis in Addition to Pentostatin in Conditioning for Canine Hematopoietic Cell Transplantation: Role in Engraftment
por: Bethge, Wolfgang A., et al.
Publicado: (2010)

Hemorrhagic cystitis following allogeneic hematopoietic cell transplantation.
por: Lee, Gyeong-Won, et al.
Publicado: (2003)

Allogeneic hematopoietic stem cell transplantation in mycosis fungoides
por: Atalla, Angelo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_foh7v92bckms55vs6v6jvrmh21